Sweetgreen, Inc. (NYSE:SG – Get Free Report) CEO Jonathan Neman sold 41,805 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $38.61, for a total transaction of $1,614,091.05. Following the completion of the sale, the chief executive officer now directly owns 1,930,228 shares in the company, valued at approximately $74,526,103.08. This trade represents a 2.12 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Jonathan Neman also recently made the following trade(s):
- On Monday, November 25th, Jonathan Neman sold 14,745 shares of Sweetgreen stock. The stock was sold at an average price of $45.00, for a total value of $663,525.00.
- On Wednesday, November 6th, Jonathan Neman sold 20,937 shares of Sweetgreen stock. The stock was sold at an average price of $40.03, for a total value of $838,108.11.
- On Monday, October 28th, Jonathan Neman sold 1,010 shares of Sweetgreen stock. The shares were sold at an average price of $40.01, for a total value of $40,410.10.
- On Friday, September 13th, Jonathan Neman sold 17,020 shares of Sweetgreen stock. The shares were sold at an average price of $35.08, for a total transaction of $597,061.60.
- On Monday, September 9th, Jonathan Neman sold 7,400 shares of Sweetgreen stock. The stock was sold at an average price of $28.81, for a total transaction of $213,194.00.
Sweetgreen Trading Down 1.1 %
Shares of NYSE:SG opened at $40.05 on Friday. The stock has a fifty day simple moving average of $37.90 and a two-hundred day simple moving average of $33.09. Sweetgreen, Inc. has a 12-month low of $9.66 and a 12-month high of $45.12. The stock has a market capitalization of $4.63 billion, a price-to-earnings ratio of -51.35 and a beta of 2.32.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on Sweetgreen
Hedge Funds Weigh In On Sweetgreen
Institutional investors and hedge funds have recently modified their holdings of the stock. Price T Rowe Associates Inc. MD boosted its stake in Sweetgreen by 47.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 55,041 shares of the company’s stock worth $1,391,000 after purchasing an additional 17,750 shares in the last quarter. Harbor Capital Advisors Inc. lifted its stake in shares of Sweetgreen by 98.4% in the second quarter. Harbor Capital Advisors Inc. now owns 18,628 shares of the company’s stock worth $561,000 after buying an additional 9,238 shares in the last quarter. SG Americas Securities LLC grew its holdings in shares of Sweetgreen by 1,101.2% during the second quarter. SG Americas Securities LLC now owns 69,176 shares of the company’s stock valued at $2,085,000 after buying an additional 63,417 shares during the last quarter. Curated Wealth Partners LLC increased its position in shares of Sweetgreen by 175.0% during the second quarter. Curated Wealth Partners LLC now owns 54,103 shares of the company’s stock valued at $1,631,000 after acquiring an additional 126,241 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC purchased a new position in Sweetgreen in the 2nd quarter worth approximately $825,000. 95.75% of the stock is currently owned by institutional investors.
About Sweetgreen
Sweetgreen, Inc, together with its subsidiaries, operates fast food restaurants serving healthy foods at scale in the United States. The company also accepts orders through its online and mobile ordering platforms, as well as sells gift cards that do not have an expiration date and can be redeemed. The company was founded in 2006 and is headquartered in Los Angeles, California.
Featured Stories
- Five stocks we like better than Sweetgreen
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Chinese Stocks to Watch as Asian Bond Market Signals Shift
- How to Use the MarketBeat Dividend Calculator
- Rideshare Rivalry: Lyft Stock Shows Potential to Outperform Uber
- How to Calculate Stock Profit
- Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair?
Receive News & Ratings for Sweetgreen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sweetgreen and related companies with MarketBeat.com's FREE daily email newsletter.